| Product Code: ETC9966864 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Generic Drug Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Generic Drug Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Generic Drug Market - Industry Life Cycle |
3.4 United States (US) Generic Drug Market - Porter's Five Forces |
3.5 United States (US) Generic Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Generic Drug Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.7 United States (US) Generic Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 United States (US) Generic Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Generic Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 United States (US) Generic Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing healthcare costs leading to a focus on cost-effective treatment options. |
4.2.2 Expired patents of branded drugs leading to a surge in generic drug demand. |
4.2.3 Government initiatives to promote generic drug usage and reduce healthcare expenditure. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for generic drug approval. |
4.3.2 Price erosion due to intense competition among generic drug manufacturers. |
4.3.3 Limited market exclusivity for generic drugs leading to pricing pressure. |
5 United States (US) Generic Drug Market Trends |
6 United States (US) Generic Drug Market, By Types |
6.1 United States (US) Generic Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Generic Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Generic Drug Market Revenues & Volume, By Simple Generics, 2021- 2031F |
6.1.4 United States (US) Generic Drug Market Revenues & Volume, By Super Generics, 2021- 2031F |
6.2 United States (US) Generic Drug Market, By Brand |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Generic Drug Market Revenues & Volume, By Pure Generic, 2021- 2031F |
6.2.3 United States (US) Generic Drug Market Revenues & Volume, By Branded Generic, 2021- 2031F |
6.3 United States (US) Generic Drug Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Generic Drug Market Revenues & Volume, By Central Nervous System (CNS), 2021- 2031F |
6.3.3 United States (US) Generic Drug Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.4 United States (US) Generic Drug Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.3.5 United States (US) Generic Drug Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.6 United States (US) Generic Drug Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.7 United States (US) Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Generic Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Generic Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Generic Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.4 United States (US) Generic Drug Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.5 United States (US) Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Generic Drug Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Generic Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Generic Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United States (US) Generic Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 United States (US) Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Generic Drug Market Import-Export Trade Statistics |
7.1 United States (US) Generic Drug Market Export to Major Countries |
7.2 United States (US) Generic Drug Market Imports from Major Countries |
8 United States (US) Generic Drug Market Key Performance Indicators |
8.1 Number of FDA approvals for generic drugs. |
8.2 Adoption rate of generic drugs by healthcare providers. |
8.3 Average cost savings achieved by switching from branded to generic drugs. |
9 United States (US) Generic Drug Market - Opportunity Assessment |
9.1 United States (US) Generic Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Generic Drug Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.3 United States (US) Generic Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 United States (US) Generic Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Generic Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 United States (US) Generic Drug Market - Competitive Landscape |
10.1 United States (US) Generic Drug Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Generic Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here